VIJYADI VATI AND KUBERAKSHA VATI IN KRICCHARTAVA (DYSMENORRHOEA)

INTERVENTION: Intervention1: Kuberaksha Vati: Group B: Minimum 50 patients of Kashatartava will be treated by Kuberaksha Vati orally. Dose ‐ 500mg twice a day with lukewarm water. Duration ‐ Drug will be started 5 days before the due date of menses and continued for 60 days thereafter. Intervention2: Vijayadi Vati: Group A: Minimum 50 patients of Kashatartava will be treated by Vijayadi Vati orally. Dose ‐ 500mg twice a day with lukewarm water. Duration ‐ Drug will be started 5 days before the due date of menses and continued for 60 days thereafter. CONDITION: chief complaint of dysmenorrhoea with scanty or average amount of menses, along with or without associated symptoms and dysmenorrhoea since more than 2 consecutive cycles. PRIMARY OUTCOME: Pain assessment on Visual Analog Scale ; Numeric Rating Scale‐‐‐‐‐‐Timepoint: 1. First follow up is done during trial after Second menses. ; 2.Final outcome is assessed after completion of trial in the next consecutive menses. ; SECONDARY OUTCOME: nausea, vomiting, giddiness, constipation, breast tenderness, diarrhea, headache, fainting‐‐‐‐‐‐Timepoint: 1. First follow up is done during trial after Second menses. ; 2.Final outcome is assessed after completion of trial in the next consecutive menses. ; INCLUSION CRITERIA: 1. Patient coming with chief complaint of dysmenorrhoea with scanty or average amount of menses. 2. Patient in age group of 16 to 30 years. 3. Patient having H/O dysmenorrhoea along with or without associated symptoms. 4. Patient suffering from dysmenorrhoea since more than 2 consecutive cycles.